Promiscuous genes and chromosomal rearrangements of hematopoietic malignancies.

被引:0
|
作者
Berger, R
机构
[1] Inst Mol Genet, CNRS, F-75010 Paris, France
[2] INSERM, U434, F-75010 Paris, France
来源
ANNALES DE GENETIQUE | 1999年 / 42卷 / 01期
关键词
hematopoietic malignancies; leukemia; chromosomes; translocation; fusion genes;
D O I
暂无
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The nonrandomness of chromosomal abnormalities of hematopoietic malignancies, which has been established twenty years ago, has evidenced a more or less close relationship between some structural chromosomal abnormalities and leukemia subtypes. The same relation was, then, shown between gene and chromosome rearrangements. It becomes now obvious that genes involved in malignant proliferations may rearrange several different partner genes, as for instance the genes MLL, localised to chromosome band 11q23, and ETV6/TEL to 12p13, The study of these rearrangements is of particular importance in order to improve our knowledge of the functions of rearranged genes as well as their normal counterparts, and to analyse mechanisms favoring the occurrence of chromosomal rearrangements in malignancies.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 50 条
  • [21] ANTIGEN RECEPTOR GENES IN HEMATOPOIETIC MALIGNANCIES
    REIS, MD
    GRIESSER, H
    MAK, TW
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) : 177 - 192
  • [22] A novel F-box protein is differentially expressed in hematopoietic malignancies.
    Banham, AH
    Cordell, JL
    Jones, M
    Liggins, AP
    Pulford, K
    Mason, DY
    BLOOD, 2001, 98 (11) : 157B - 157B
  • [23] Non-myeloablative hematopoietic stem cell transplantation for hematological malignancies.
    Yamane, T
    Aoyama, Y
    Hakamae, H
    Hasegawa, T
    Yamamura, R
    Sakamoto, C
    Terada, Y
    Koh, G
    Ohta, K
    Hino, M
    BLOOD, 2003, 102 (11) : 473B - 473B
  • [24] Aberrant DNA methylation of the C/EBPalpha promoter region in hematopoietic malignancies.
    Jost, E
    do O, N
    Herman, JG
    Osieka, R
    Galm, O
    BLOOD, 2005, 106 (11) : 140B - 140B
  • [25] Mutations of a checkpoint gene, Chk2, in primary hematopoietic malignancies.
    Hangaishi, A
    Ogawa, S
    Ying, Q
    Lili, W
    Hosoya, N
    Imai, Y
    Yuji, K
    Hirai, H
    BLOOD, 2000, 96 (11) : 173B - 173B
  • [26] Change of expression of estrogen-regulatory genes in uterine malignancies.
    Kutilin, Denis S.
    Kit, Oleg Ivanovich
    Vodolazhsky, Dmitry I.
    Nikitin, Ivan
    Moiseenko, Tatiana
    Frantsiyants, Elena Mikhaylovna
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Chromosomal aberrations and fusion genes in myeloid malignancies
    Gianfelici, Valentina
    Lahortiga, Idoya
    Cools, Jan
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (04) : 381 - 393
  • [28] Determination of a HLA II promiscuous peptide cocktail as potential vaccine against EBV latency II malignancies.
    Depil, S
    Morales, O
    Maillere, B
    Delhem, N
    Francois, V
    Georges, B
    Morschhauser, F
    Auriault, C
    Pancre, V
    BLOOD, 2005, 106 (11) : 426A - 426A
  • [29] Promiscuous genes involved in recurrent chromosomal translocations in soft tissue tumours
    Antonescu, Cristina R.
    Dal Cin, Paola
    PATHOLOGY, 2014, 46 (02) : 105 - 112
  • [30] Involvement of the CBP and p300 genes in translocations in hematologic malignancies.
    Taki, T
    Ida, K
    Kitabayashi, I
    Taniwaki, M
    Ohki, M
    Sasaki, J
    Bessho, F
    Yanagisawa, M
    Hayashi, Y
    BLOOD, 1997, 90 (10) : 1421 - 1421